image gastro oesophageal reflux disease

Gastro-oesophageal reflux disease (GORD) is a common presentation in the western world with a prevalence of ca 10-28 % in adults and a growing prevalence in children. Prior use of non-steroidal anti-inflammatory drugs, smoking, excess body weight and gastrointestinal and cardiac conditions are all associated with an increased risk of a diagnosis of GORD, making it important to advise on lifestyle changes in primary care before starting to prescribe. Proton pump inhibitors (PPI) prescriptions have risen over the last ten years, with up to 41% of elderly patients on PPIs. This primary care focused course of four fifteen minute modules aims to improve management of GORD in primary care, whilst reducing unnecessary prescribing.

This course was sponsored by RB.

Reckitt Benckiser logo
Curriculum: Gastroenterology
Time to complete this course: 60 minutes
Date of publication: 15 January 2018
Reviewed and updated: 15 June 2021
Mode: Course
Podcast icon: No
Course index: Show
Section titles: Hide
Breadcrumb: Hide